Cubist Systematic Strategies’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-171,497
| Closed | -$1.05M | – | 3762 |
|
|
2021
Q3 | $1.05M | Buy |
171,497
+90,961
| +113% | +$567K | 0.01% | 1487 |
|
|
2021
Q2 | $663K | Sell |
80,536
-17,015
| -17% | -$145K | 0.01% | 1823 |
|
|
2021
Q1 | $873K | Buy |
97,551
+81,207
| +497% | +$931K | 0.01% | 1621 |
|
|
2020
Q4 | $189K | Buy |
16,344
+66
| +0.4% | +$767 | ﹤0.01% | 2262 |
|
|
2020
Q3 | $169K | Sell |
16,278
-47,097
| -74% | -$577K | ﹤0.01% | 2176 |
|
|
2020
Q2 | $833K | Sell |
63,375
-24,500
| -28% | -$254K | 0.01% | 1291 |
|
|
2020
Q1 | $692K | Sell |
87,875
-24,862
| -22% | -$374K | 0.02% | 1057 |
|
|
2019
Q4 | $2.33M | Buy |
+112,737
| New | +$1.9M | 0.04% | 662 |
|
|
2019
Q3 | – | Sell |
-19,069
| Closed | -$235K | – | 2603 |
|
|
2019
Q2 | $235K | Buy |
19,069
+8,915
| +88% | +$103K | ﹤0.01% | 1966 |
|
|
2019
Q1 | $127K | Buy |
10,154
+8,313
| +452% | +$111K | ﹤0.01% | 1943 |
|
|
2018
Q4 | $21K | Sell |
1,841
-591
| -24% | -$9.27K | ﹤0.01% | 1946 |
|
|
2018
Q3 | $46K | Buy |
+2,432
| New | +$55.9K | ﹤0.01% | 1721 |
|
|
2018
Q2 | – | Sell |
-17,022
| Closed | -$381K | – | 2151 |
|
|
2018
Q1 | $381K | Buy |
+17,022
| New | +$415K | 0.02% | 988 |
|
|
2015
Q4 | – | Sell |
-22,710
| Closed | -$337K | – | 2032 |
|
|
2015
Q3 | $337K | Buy |
+22,710
| New | +$533K | 0.02% | 1179 |
|
|
2015
Q2 | – | Sell |
-9,207
| Closed | -$207K | – | 2128 |
|
|
2015
Q1 | $207K | Buy |
+9,207
| New | +$213K | 0.01% | 1512 |
|